POM-V Prescription Required

Parofor Crypto 140 000 IU/ml Oral Solution for Sheep and Goats

Active ingredient: Paromomycin

Form

Liquid

Species

Goats Sheep

Manufacturer

Huvepharma N.V.

VMD MA No.

30282/5013

What it's used for

Reduction of the severity and the duration of diarrhoea associated with Cryptosporidium parvum in individual animals confirmed to have cryptosporidial oocy...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Paromomycin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Parofor Crypto 140 000 IU/ml Oral Solution for Sheep and Goats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Reduction of the severity and the duration of diarrhoea associated with
Cryptosporidium parvum in individual animals confirmed to have cryptosporidial
oocysts in their faeces.
Paromomycin reduces faecal oocyst shedding.

Do not use in cases of known hypersensitivity to the active substance, to other
aminoglycosides or to any of the excipients.
Do not use in cases with impaired function of the kidneys or liver.
Do not use in ruminating animals.

Revised: April 2024
AN: 00641/2023

Sheep and goats:
Undetermined frequency (cannot
be estimated from available data)
Nephropathy (nephrotoxicity)
Internal ear disorder
(ototoxicity)
1
can be caused by aminoglycoside antibiotics such as paromomycin
Reporting adverse events is important. It allows continuous safety monitoring of
a veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder or its local
representative or the national competent authority via the national reporting
system. See the package leaflet for respective contact details.

Lambs and goat kids should only receive the treatment upon confirmation of
cryptosporidial oocysts in their faeces and as soon as possible after the onset of
diarrhoea (see section 3.5).
In field studies investigating the effect of the veterinary medicinal product on
diarrhoea associated with cryptosporidiosis, the median duration of clinically
relevant diarrhoea was 3 days for treated lambs compared to 6 days for
untreated lambs and 4 days in treated kid goats compared to 7 days for the
untreated goats, during the 7-day treatment period.

Special precautions for use in animals
Since the veterinary medicinal product is potentially ototoxic and nephrotoxic, it
is recommended to assess kidney function, especially when considering
administration of the veterinary medicinal product to newborn animals due to
the known higher gastrointestinal absorption of paromomycin in neonates. This
higher absorption could lead to an increased risk of oto- and nephrotoxicity.
The use of the veterinary medicinal product in neonates should be based on a
benefit/risk assessment by the responsible veterinarian.
The use of the veterinary medicinal product should be combined with good
management practices e.g. good hygiene, proper ventilation, no overstocking
and through cleansing and disinfection.
Aminoglycosides are considered as critically important in human medicine. Use
of the veterinary medicinal product deviating from the instructions given in the
SPC may increase the prevalence of bacteria resistant to paromomycin and
may decrease the effectiveness of treatment with aminoglycosides due to the
potential for cross-resistance.
Special precautions to be take by the person administering the veterinary
medicinal product to animals
This veterinary medicinal product contains paromomycin, which can cause
allergic reactions in some people.
People with known hypersensitivity to paromomycin or to any other
aminoglycosides should avoid contact with the veterinary medicinal product.
Avoid contact with the skin and eyes.
In the event of accidental contact with the skin or eyes, rinse with plenty of
water.
If you develop symptoms following exposure, such as skin rash, you should
seek medical advice immediately and show the package leaflet or the label to
the physician. Swelling of the face, lips and eyes or difficulty in breathing are
more serious symptoms and require urgent medical attention.
Personal protective equipment consisting of protective clothing and impervious
gloves should be worn when handling the veterinary medicinal product. Do not
eat, drink and smoke when handling the veterinary medicinal product.
Do not ingest. In case of accidental ingestion, seek medical advice immediately
and show the package leaflet or the label to the physician.
Wash hands after use.

Revised: April 2024
AN: 00641/2023
Special precautions for the protection of the environment
Not applicable.
Other precautions:
Not applicable.

General anaesthetics and muscle relaxing products increase the neuro-blocking
effect of aminoglycosides. This may cause paralysis and apnoea.
Do not use concurrently with strong diuretics and potentially oto- or nephrotoxic
substances

Do not store above 25°C.

Meat and offal: 24 days
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.